Certified by Founder Lodge
AstronauTx
United Kingdom - London, England
START UP
1 Disclosed Funding Rounds $58,462,000
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
AstronauTx is at the forefront of a novel approach to treating neurodegenerative diseases. We have a unique portfolio of small-molecule therapeutics to restore dysregulated physiology to both
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| October, 09 ,2023 | Series A | $58,462,000 |
EQT Life Sciences
Dementia Discovery Fund (DDF)
Bristol Myers Squibb
MPM BioImpact
Brandon Capital
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Wify Technologies | $2,993,443 | (Jul 2, 2024)
Waypoint Bio | $14,500,000 | (Jul 2, 2024)
K Health | $50,000,000 | (Jul 2, 2024)
Vytal | The reuse system | $6,644,850 | (Jul 2, 2024)
Pieces for Developers | $13,500,000 | (Jul 2, 2024)
